Characteristics of a transgender and gender-diverse patient population in Utah: Use of electronic health records to advance clinical and health equity research.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 19 12 2023
accepted: 15 04 2024
medline: 7 5 2024
pubmed: 7 5 2024
entrez: 7 5 2024
Statut: epublish

Résumé

Transgender and gender-diverse (TGD) people, individuals whose gender identity differs from their sex assigned at birth, face unique challenges in accessing gender-affirming care and often experience disparities in a variety of health outcomes. Clinical research on TGD health is limited by a lack of standardization on how to best identify these individuals. The objective of this retrospective cohort analysis was to accurately identify and describe TGD adults and their use of gender-affirming care from 2003-2023 in a healthcare system in Utah, United States. International Classification of Disease (ICD)-9 and 10 codes and surgical procedure codes, along with sexual orientation and gender identity data were used to develop a dataset of 4,587 TGD adults. During this time frame, 2,985 adults received gender-affirming hormone therapy (GAHT) and/or gender-affirming surgery (GAS) within one healthcare system. There was no significant difference in race or ethnicity between TGD adults who received GAHT and/or GAS compared to TGD adults who did not receive such care. TGD adults who received GAHT and/or GAS were more likely to have commercial insurance coverage, and adults from rural communities were underrepresented. Patients seeking estradiol-based GAHT tended to be older than those seeking testosterone-based GAHT. The first GAS occurred in 2013, and uptake of GAS have doubled since 2018. This study provides a methodology to identify and examine TGD patients in other health systems and offers insights into emerging trends and access to gender-affirming care.

Identifiants

pubmed: 38713697
doi: 10.1371/journal.pone.0302895
pii: PONE-D-23-40640
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0302895

Informations de copyright

Copyright: © 2024 Ho et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Tiffany F Ho (TF)

Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Brian Zenger (B)

Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri, United States of America.

Bayarmaa Mark (B)

Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Laurel Hiatt (L)

Department of Human Genetics, Us1niversity of Utah, Salt Lake City, Utah, United States of America.

Erika Sullivan (E)

Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Benjamin A Steinberg (BA)

Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Ann Lyons (A)

Data Science Services, University of Utah, Salt Lake City, Utah, United States of America.

Adam M Spivak (AM)

Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Cori Agarwal (C)

Department of Surgery, Division of Plastic Surgery, University of Utah, Salt Lake City, Utah, United States of America.

Marisa Adelman (M)

Department of Obstetrics & Gynecology, University of Utah, Salt Lake City, Utah, United States of America.

James Hotaling (J)

Department of Surgery, Division of Urology, University of Utah, Salt Lake City, Utah, United States of America.

Bernadette Kiraly (B)

Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Sharon Talboys (S)

Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH